Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration

Purpose: We evaluate the impact of test target location in assessing rod-mediated dark adaptation (RMDA) along the transition from normal aging to intermediate age-related macular degeneration (AMD). We consider whether RMDA slows because the test locations are near mechanisms leading to or resultin...

Full description

Bibliographic Details
Main Authors: Cynthia Owsley, PhD, MSPH, Thomas A. Swain, MPH, Gerald McGwin, Jr., PhD, MS, Mark E. Clark, MEng, Deepayan Kar, MS, Christine A. Curcio, PhD
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Ophthalmology Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666914523000064
_version_ 1827919337109848064
author Cynthia Owsley, PhD, MSPH
Thomas A. Swain, MPH
Gerald McGwin, Jr., PhD, MS
Mark E. Clark, MEng
Deepayan Kar, MS
Christine A. Curcio, PhD
author_facet Cynthia Owsley, PhD, MSPH
Thomas A. Swain, MPH
Gerald McGwin, Jr., PhD, MS
Mark E. Clark, MEng
Deepayan Kar, MS
Christine A. Curcio, PhD
author_sort Cynthia Owsley, PhD, MSPH
collection DOAJ
description Purpose: We evaluate the impact of test target location in assessing rod-mediated dark adaptation (RMDA) along the transition from normal aging to intermediate age-related macular degeneration (AMD). We consider whether RMDA slows because the test locations are near mechanisms leading to or resulting from high-risk extracellular deposits. Soft drusen cluster under the fovea and extend to the inner ring of the ETDRS grid where rods are sparse. Subretinal drusenoid deposits (SDDs) appear first in the outer superior subfield of the ETDRS grid where rod photoreceptors are maximal and spread toward the fovea without covering it. Design: Cross-sectional. Participants: Adults ≥ 60 years with normal older maculas, early AMD, or intermediate AMD as defined by the Age-Related Eye Disease Study (AREDS) 9-step and Beckman grading systems. Methods: In 1 eye per participant, RMDA was assessed at 5° and at 12° in the superior retina. Subretinal drusenoid deposit presence was identified with multi-modal imaging. Main Outcome Measures: Rod intercept time (RIT) as a measure of RMDA rate at 5° and 12°. Results: In 438 eyes of 438 persons, RIT was significantly longer (i.e., RMDA is slower) at 5° than at 12° for each AMD severity group. Differences among groups were bigger at 5° than at 12°. At 5°, SDD presence was associated with longer RIT as compared to SDD absence at early and intermediate AMD but not in normal eyes. At 12°, SDD presence was associated with longer RIT in intermediate AMD only, and not in normal or early AMD eyes. Findings were similar in eyes stratified by AREDS 9-step and Beckman systems. Conclusions: We probed RMDA in relation to current models of deposit-driven AMD progression organized around photoreceptor topography. In eyes with SDD, slowed RMDA occurs at 5° where these deposits typically do not appear until later in AMD. Even in eyes lacking detectable SDD, RMDA at 5° is slower than at 12°. The effect at 5° may be attributed to mechanisms associated with the accumulation of soft drusen and precursors under the macula lutea throughout adulthood. These data will facilitate the design of efficient clinical trials for interventions that aim to delay AMD progression. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.
first_indexed 2024-03-13T03:56:28Z
format Article
id doaj.art-f5cef3fe2f874ce5b04dda4be9179a6c
institution Directory Open Access Journal
issn 2666-9145
language English
last_indexed 2024-03-13T03:56:28Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Ophthalmology Science
spelling doaj.art-f5cef3fe2f874ce5b04dda4be9179a6c2023-06-22T05:05:46ZengElsevierOphthalmology Science2666-91452023-06-0132100274Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular DegenerationCynthia Owsley, PhD, MSPH0Thomas A. Swain, MPH1Gerald McGwin, Jr., PhD, MS2Mark E. Clark, MEng3Deepayan Kar, MS4Christine A. Curcio, PhD5Department of Ophthalmology & Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Correspondence: Cynthia Owsley, PhD, MSPH, Department of Ophthalmology & Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, 1720 University Blvd., Suite 609, Birmingham AL 35294-0009Department of Ophthalmology & Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AlabamaDepartment of Ophthalmology & Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AlabamaDepartment of Ophthalmology & Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AlabamaDepartment of Ophthalmology & Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AlabamaDepartment of Ophthalmology & Visual Sciences, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AlabamaPurpose: We evaluate the impact of test target location in assessing rod-mediated dark adaptation (RMDA) along the transition from normal aging to intermediate age-related macular degeneration (AMD). We consider whether RMDA slows because the test locations are near mechanisms leading to or resulting from high-risk extracellular deposits. Soft drusen cluster under the fovea and extend to the inner ring of the ETDRS grid where rods are sparse. Subretinal drusenoid deposits (SDDs) appear first in the outer superior subfield of the ETDRS grid where rod photoreceptors are maximal and spread toward the fovea without covering it. Design: Cross-sectional. Participants: Adults ≥ 60 years with normal older maculas, early AMD, or intermediate AMD as defined by the Age-Related Eye Disease Study (AREDS) 9-step and Beckman grading systems. Methods: In 1 eye per participant, RMDA was assessed at 5° and at 12° in the superior retina. Subretinal drusenoid deposit presence was identified with multi-modal imaging. Main Outcome Measures: Rod intercept time (RIT) as a measure of RMDA rate at 5° and 12°. Results: In 438 eyes of 438 persons, RIT was significantly longer (i.e., RMDA is slower) at 5° than at 12° for each AMD severity group. Differences among groups were bigger at 5° than at 12°. At 5°, SDD presence was associated with longer RIT as compared to SDD absence at early and intermediate AMD but not in normal eyes. At 12°, SDD presence was associated with longer RIT in intermediate AMD only, and not in normal or early AMD eyes. Findings were similar in eyes stratified by AREDS 9-step and Beckman systems. Conclusions: We probed RMDA in relation to current models of deposit-driven AMD progression organized around photoreceptor topography. In eyes with SDD, slowed RMDA occurs at 5° where these deposits typically do not appear until later in AMD. Even in eyes lacking detectable SDD, RMDA at 5° is slower than at 12°. The effect at 5° may be attributed to mechanisms associated with the accumulation of soft drusen and precursors under the macula lutea throughout adulthood. These data will facilitate the design of efficient clinical trials for interventions that aim to delay AMD progression. Financial Disclosure(s): Proprietary or commercial disclosure may be found after the references.http://www.sciencedirect.com/science/article/pii/S2666914523000064Normal agingRod-mediated dark adaptationDrusenSubretinal drusenoid depositsAge-related macular degeneration
spellingShingle Cynthia Owsley, PhD, MSPH
Thomas A. Swain, MPH
Gerald McGwin, Jr., PhD, MS
Mark E. Clark, MEng
Deepayan Kar, MS
Christine A. Curcio, PhD
Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration
Ophthalmology Science
Normal aging
Rod-mediated dark adaptation
Drusen
Subretinal drusenoid deposits
Age-related macular degeneration
title Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration
title_full Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration
title_fullStr Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration
title_full_unstemmed Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration
title_short Biologically Guided Optimization of Test Target Location for Rod-mediated Dark Adaptation in Age-related Macular Degeneration
title_sort biologically guided optimization of test target location for rod mediated dark adaptation in age related macular degeneration
topic Normal aging
Rod-mediated dark adaptation
Drusen
Subretinal drusenoid deposits
Age-related macular degeneration
url http://www.sciencedirect.com/science/article/pii/S2666914523000064
work_keys_str_mv AT cynthiaowsleyphdmsph biologicallyguidedoptimizationoftesttargetlocationforrodmediateddarkadaptationinagerelatedmaculardegeneration
AT thomasaswainmph biologicallyguidedoptimizationoftesttargetlocationforrodmediateddarkadaptationinagerelatedmaculardegeneration
AT geraldmcgwinjrphdms biologicallyguidedoptimizationoftesttargetlocationforrodmediateddarkadaptationinagerelatedmaculardegeneration
AT markeclarkmeng biologicallyguidedoptimizationoftesttargetlocationforrodmediateddarkadaptationinagerelatedmaculardegeneration
AT deepayankarms biologicallyguidedoptimizationoftesttargetlocationforrodmediateddarkadaptationinagerelatedmaculardegeneration
AT christineacurciophd biologicallyguidedoptimizationoftesttargetlocationforrodmediateddarkadaptationinagerelatedmaculardegeneration